La Jolla Pharmaceutical News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

01.08.22	SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates RFP, VIVO, LJPC, SMED (PR Newswire)
27.07.22	INVESTIGATION ALERT: Halper Sadeh LLP Investigates ZEN, LJPC, VIVO, PCSB (PR Newswire)
18.07.22	INVESTIGATION ALERT: Halper Sadeh LLP Investigates LJPC, ZEN, RFP, VHAQ (PR Newswire)
12.07.22	INVESTIGATION NOTICE: Halper Sadeh LLP Investigates RFP, LJPC, FSI, SYRS (PR Newswire)
11.07.22	Innoviva To Acquire La Jolla Pharma In $149 Mln Deal (RTTNews)
12.01.21	Stock Alert: La Jolla Pharmaceutical Soars On Deal With PAION (RTTNews)
28.05.20	PHAS To Begin COVID-19 Drug Trial In June, MRSN Hits New High, LJPC Plunges, RCUS On Watch (RTTNews)
13.03.20	Stock Alert: La Jolla Pharma Shares Surge 30% In Premarket (RTTNews)
04.02.20	Stock To Watch: La Jolla Pharma (LJPC) (RTTNews)
17.12.19	Top Gainers: CLSD Making A Second Try, RLMD Abuzz, Busy Year Ahead For BTAI (RTTNews)
26.11.19	CCXI Is Red Hot, ZGNX On Watch, FDA Snubs ADMP (RTTNews)
08.01.19	CFRX Fails To Impress, LJPC Falls On Giapreza Outlook, AXGN Disappoints (RTTNews)
26.10.18	FATE Catches Eyes, LJPC Upbeat, CLSD To Submit XIPERE NDA By Year-end (RTTNews)
10.08.18	LJPC, PTLA Disappoint, SBPH Waiting To ACHIEVE, Busy Months Ahead For TCON (RTTNews)
01.05.18	CalciMedica Names Two Senior Executives to its Board of Directors (PR Newswire)
23.03.18	Fabry Disease Drug OK'd In Japan, FDA Delays Decision On Azedra, HTGM On Watch (RTTNews)
07.01.18	New Drugs Approved In December (RTTNews)
27.12.17	Biotech Stocks Facing FDA Decision In January 2018 (RTTNews)
27.12.17	Famous Five: Did You Invest In These 5 Biotech Stocks? (RTTNews)
22.12.17	La Jolla Pharmaceutical Jumps On FDA Approval Of Giapreza (RTTNews)
11.12.17	Watch Out For BLUE, BPMC, GBT, KURA, KDMN, SYRS Today (RTTNews)
29.08.17	KMDA Slips On AAT Therapy Concerns, ETRM Gains Weight, LJPC On Watch (RTTNews)
02.08.17	Breakfast Technical Briefing on Biotech Stocks -- Dynavax Technologies, Keryx Biopharma, La Jolla Pharma, and Moleculin Biotech (PR Newswire)
19.06.17	Today's Research Report Coverage on Biotech Stocks -- Cyclacel Pharma, Cytori Therapeutics, La Jolla Pharma, and Moleculin Biotech (PR Newswire)
10.04.17	Research Reports Initiation on Biotech Stocks -- La Jolla Pharma, Spectrum Pharma, Advaxis, and Aevi Genomic (PR Newswire)
22.03.17	Gainers & Losers Of Mar.21: PULM, AST, GNMX, AXSM, LJPC... (RTTNews)
28.02.17	LJPC Climbs 76%, VTVT On Track, Eventful October Awaits ACRX, ATRS (RTTNews)
27.02.17	MÄRKTE USA/Dow mit längster Gewinnserie seit 30 Jahren - Trump-Rede im Blick (Dow Jones)
27.02.17	MÄRKTE USA/Rekordlauf der Wall Street gerät ins Stocken (Dow Jones)
27.02.17	MÄRKTE USA/Rekordlauf der Wall Street gerät ins Stocken (Dow Jones)
11.09.15	La Jolla Gets Positive Opinion From European Orphan Committee For LJPC-401 (RTTNews)
12.08.15	INGN Lifts Outlook, BCLI Awaits DSMB Review, TRVN To Report Data Next Month (RTTNews)
07.08.15	La Jolla Pharma Widens (RTTNews)
25.03.15	CLRB Sets Agenda, FDA Authorizes Xpert Ebola, Lpath Loses Track, OCAT Eyes PSCs (RTTNews)
17.03.15	BDSI On Watch, Busy Months Ahead For LJPC, AQXP Awaits Leadership (RTTNews)
05.06.14	HALO Brightens, CPXX Eyes Long Haul, LJPC Awaits Next Catalyst (RTTNews)
11.03.14	La Jolla Experimental Kidney Drug Phase 2 Trial Meets Primary Goal, Stock Surges (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Geberit	511.40	3.38 %	K V
UBS Group	30.03	2.21 %	K V
Logitech Intl	80.66	1.87 %	K V
Swiss Re	134.20	1.44 %	K V
Zurich Insur Gr	536.80	1.40 %	K V
Roche Hldg G	264.50	0.42 %	K V
Novartis	90.42	0.34 %	K V
Alcon	75.90	0.26 %	K V
CieFinRichemont	139.65	-0.39 %	K V
Nestle	73.72	-0.59 %	K V

Nachrichten zu La Jolla Pharmaceutical Co

Aktien Top/Flop

Meistgelesene Nachrichten